Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Frontiers in Immunology, 2026
Multidimensional neuropsychological heterogeneity in obstructive sleep apnea: deep clinical phenotyping in a single-center cohort, population proteomic context, and depressive-burden risk stratification

Wang X., Jiang Y., Yu L. et al.

Olink Explore 3072/384Respiratory DiseasesNeurologyPatient StratificationPlasma

Frontiers in Psychiatry, 2026
A discovery plasma proteome signature in military personnel with chronic PTSD symptoms

Lim A., Robey C., Kenney K. et al.

Olink Explore HTNeurologyPathophysiologyPatient Stratification

Brain, Behavior, and Immunity, 2026
DREADDs-Gi mediated inhibition of myeloid cells leads to anti-inflammatory signalling, shrinkage of microglia and acute heart failure in Cx3cr1Cre mice

Holde F., Pedersen T., Frandsen S. et al.

Olink Target 96 MouseCVDPathophysiologyMouse Plasma

Clinical Proteomics, 2026
Pre-surgical immune-proteomic profiles in serum identify inflamed and suppressed immune states associated with biochemical recurrence and PSA persistence in prostate cancer

Desiati I., Bozorgpana S., Ramberg H. et al.

Olink Target 96OncologyPatient StratificationSerum

Journal of Neurology, 2026
Decreased cerebrospinal fluid TNFRSF8 (sCD30) confirmed as a biomarker of Huntington’s disease progression

Grétarsdóttir H., Cunningham J., Rasmusson A. et al.

Olink Explore 3072/384NeurologyPathophysiologyPatient StratificationCSF

International Journal of Radiation Oncology*Biology*Physics, 2026
Safety and Biomarker Analysis of NRG-LU004: Phase I Trial of Accelerated or Conventionally Fractionated Radiotherapy Combined With Durvalumab in PD-L1 High Locally Advanced Non-Small Cell Lung Cancer

Lin S., Pugh S., Valle D. et al.

Olink Target 96OncologyImmunotherapyPathophysiologyPlasma

Experimental Gerontology, 2026
Proteomic signatures of systemic inflammation in aging, multimorbidity, and mortality

Jiang Z., Ling D., Chen Z. et al.

Olink Explore 3072/384AgingPathophysiologyPlasma

Cell Death & Disease, 2026
A pro-inflammatory metastasis-associated macrophage subset induces tumor-promoting mesothelial cell conversion in ovarian cancer via IL-1α secretion

Heidemann S., Finkernagel F., Steitz A. et al.

Olink Explore 3072/384OncologyPathophysiologyCell Culture Supernatant

PLOS Medicine, 2026
Protein mediators of chronic kidney disease in Type 2 diabetes: A mendelian randomization study

Liang K., Zheng T., Tan D. et al.

Olink Explore 3072/384Metabolic DiseasesNephrologyPathophysiologyPlasma

International Journal of Molecular Sciences, 2026
Integrative Proteogenomics and Single-Cell Transcriptomics Prioritize Candidate Causal Proteins and Therapeutic Targets in Age-Related Macular Degeneration

Wen L., Li F., Liu Y. et al.

Olink Explore 3072/384OphthalmologyPathophysiologyPlasma

Inflammation, 2026
Targeting E-Selectin and ICAM1 Suppresses Endometriosis Progression by Disrupting the Inflammation–Fibrosis Axis and Reducing Local M2 Macrophage Infiltration

Wu Y., Ye X., Zheng A. et al.

Olink Target 96Immunological & Inflammatory DiseasesGynecologyPathophysiologyMouse Tissue Lysate

Nature Metabolism, 2026
Paediatric proteomic signatures of cardiometabolic disease-associated traits predict adult disease outcomes

Landman J., Highland H., Perry A. et al.

Olink Explore 3072/384Olink Explore HTMetabolic DiseasesCVDNephrologyPathophysiologyPatient StratificationPlasma

Clinical and Translational Medicine, 2026
Bevacizumab plus nab‐paclitaxel and platinum as second‐line therapy for driver‐gene‐negative non‐squamous non‐small cell lung cancer after immunochemotherapy: A prospective single‐arm single‐centre study

Lin Y., Yu Y., Hu Z. et al.

Olink Target 96OncologyImmunotherapyPathophysiologyPlasma

European Journal of Medical Research, 2026
Strong molecular regulation of PARK7 with limited causal evidence for lung squamous cell carcinoma susceptibility: an integrative reanalysis

Li X., Zhang F., Li Y. et al.

Olink Explore 3072/384OncologyPathophysiologyPlasma

Journal of Anatomy, 2026
Immune proteomic associations with indices of cortical development in 5‐year‐old children

Barron A., Rosberg A., Tuulari J. et al.

Olink Explore 3072/384NeurologyPediatricsPathophysiologySerum

Heart & Lung, 2026
Glucagon-like peptide-1 receptor activation, inflammation and heart failure: Insights from genetic analysis

Tian Y., Sheng C., Zhu J. et al.

Olink Target 96CVDPathophysiologyPlasma

GeroScience, 2026
Parental longevity and polygenic longevity scores in relation to ageing-related factors in a population of 70-year-olds followed over six years: The Gothenburg H70 Birth Cohort Study

Seidu N., Rydén L., Skoog J. et al.

Olink Target 48AgingPathophysiologyPlasma

Thorax, 2026
Markers of microvascular instability predict severity and survival in idiopathic pulmonary fibrosis

Csordas D., Ma S., Huang Y. et al.

Olink Explore 3072/384Respiratory DiseasesPathophysiologyPatient StratificationPlasma

ERJ Open Research, 2026
Circulating proteins in common variable immunodeficiency with granulomatous lymphocytic interstitial lung disease – A Nordic cross-sectional multi-centre study

Fraz M., Michelsen A., Hol H. et al.

Olink Target 96Respiratory DiseasesImmunological & Inflammatory DiseasesPathophysiologyPatient StratificationPlasma

Nature Communications, 2026
Evaluating the consequences of childhood adiposity on the human plasma proteome at four timepoints across the lifecourse

Dickson P., Power G., Niu L. et al.

Olink Target 96Olink Explore 3072/384Metabolic DiseasesPathophysiologyPlasma

4520 publications